8
Oct
2024

Zhejiang Hengkang pharmaceutical Co., Lt

Exhibitor at CPHI Milan 2024 stand 3B118, API
About Us

Zhejiang Hengkang Pharmaceutical Co. Ltd. was established in 2004, specialized in APIs development, GMP manufacturing and marketing, it provides the most innovative intermediates, APIs, nucleoside, phosphoramidite, dietary supplement to world-wide customers. It has passed the official inspection of domestic and foreign drug administration for many times, such as China NMPA, EU EDQM, Japan PMDA, Korea KFDA, etc., and has successively obtained CEP certificates.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2022
    On CPHI since
  • 500 - 999
    Employees
Company types
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 3B118, API

Products Featured at CPHI Milan 2024

  • Vonoprazan fumarate

    Product Vonoprazan fumarate

    Zhejiang Hengkang Pharmaceutical Co. Ltd. has the capabilities and capacities to manufacture and deliver Vonoprazan fumarate in accordance with global regulations. Contact us for more information.
  • Deferasirox

    Product Deferasirox

    Zhejiang Hengkang Pharmaceutical Co. Ltd. has the capabilities and capacities to manufacture and deliver Deferasirox in accordance with global regulations. Contact us for more information.
  • Mirabegron

    Product Mirabegron

    Zhejiang Hengkang Pharmaceutical Co. Ltd. has the capabilities and capacities to manufacture and deliver Mirabegron in accordance with global regulations. Contact us for more information.
  • Eltrombopag

    Product Eltrombopag

    Zhejiang Hengkang Pharmaceutical Co. Ltd. has the capabilities and capacities to manufacture and deliver Eltrombopag in accordance with global regulations. Contact us for more information.
  • Saxagliptin

    Product Saxagliptin

    Zhejiang Hengkang Pharmaceutical Co. Ltd. has the capabilities and capacities to manufacture and deliver Saxagliptin in accordance with global regulations. Contact us for more information.